Tc-99m nofetumomab merpentan complements an equivocal bone scan for detecting skeletal metastatic disease from lung cancer.
Straka
M R
MR
Department of Radiology, The Western Pennsylvania Hospital, Pittsburgh 15224, USA.
Joyce
J M
JM
Myers
D T
DT
D000368:Aged; D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D001859:Bone Neoplasms / Q000000981:diagnostic imaging* / Q000556:secondary*; D002289:Carcinoma, Non-Small-Cell Lung / Q000473:pathology; D018288:Carcinoma, Small Cell / Q000473:pathology; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000473:pathology*; D015609:Organotechnetium Compounds; D016719:Radioimmunodetection; D019275:Radiopharmaceuticals; D015899:Tomography, Emission-Computed, Single-Photon
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D015609:Organotechnetium Compounds; D019275:Radiopharmaceuticals; C109626:technetium Tc 99m-nofetumomab merpentan